Kidney injury in infants and children with iron-deficiency anemia before and after iron treatment

Hematology

Volumn 22, Issue 9, 2017, Pages 565-570

  Hassan, Rasha H ^a   Kandil, Shaimaa M ^a   Zeid, Mayada S ^a   Zaki, Maysaa E ^a   Fouda, Ashraf E ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

iron treatment; iron deficiency anemia; Kidney injury

Indexed keywords

FATTY ACID BINDING PROTEIN; FERRITIN; HEMOGLOBIN; IRON; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSFERRIN; BIOLOGICAL MARKER; FABP1 PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; INFANT; IRON BINDING CAPACITY; IRON DEFICIENCY ANEMIA; IRON THERAPY; KIDNEY INJURY; MALE; MEAN CORPUSCULAR VOLUME; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ANEMIA, IRON-DEFICIENCY; COMPLICATION; KIDNEY DISEASES; PRESCHOOL CHILD; TREATMENT OUTCOME; URINE;

ANEMIA, IRON-DEFICIENCY; BIOMARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FATTY ACID-BINDING PROTEINS; FEMALE; HUMANS; INFANT; IRON; KIDNEY DISEASES; LIPOCALIN-2; MALE; TREATMENT OUTCOME;

EID: 85019262280     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245332.2017.1325587     Document Type: Article

References (28)

1. McLean E, Cogswell M, Egli I, et al. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr. 2009;12(4):444–454. Available from:https://www.ncbi.nlm.nih.gov/pubmed/18498676 doi:10.1017/S1368980008002401
2. WHO. Micronutrient Deficiencies-Iron Deficiency Anemia. [cited 2017 Feb 3]. Available from:http://www.who.int/nutrition/topics/ida/en/
3. Grantham-McGregor S, Ani C., A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr. 2001;131(2S-2):649S–666S. Available from:https://www.ncbi.nlm.nih.gov/pubmed/11160596
4. Black MM, Quigg AM, Hurley KM, et al. Iron deficiency and iron-deficiency anemia in the first two years of life:strategies to prevent loss of developmental potential. Nutr Rev. 2011;69(Suppl. 1):S64–S70. Available from:https://www.ncbi.nlm.nih.gov/pubmed/22043885 doi:10.1111/j.1753-4887.2011.00435.x
5. Scott SP, Chen-Edinboro LP, Caulfield LE, et al. The impact of anemia on child mortality:an updated review. Nutrients. 2014;6(12):5915–5932. Available from:https://www.ncbi.nlm.nih.gov/pubmed/25533005 doi:10.3390/nu6125915
6. Mårtensson J, Martling CR, Bell M., Novel biomarkers of acute kidney injury and failure:clinical applicability. Br J Anaesth. 2012;109(6):843–850. Available from:https://www.ncbi.nlm.nih.gov/pubmed/23048068 doi:10.1093/bja/aes357
7. McCullough PA, Bouchard J, Waikar SS, et al. Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury:executive summary from the tenth consensus conference of the acute dialysis quality initiative (ADQI). Contrib Nephrol. 2013;182:5–12. Available from:https://www.ncbi.nlm.nih.gov/pubmed/23689652 doi:10.1159/000349962
8. Mishra J, Mori K, Ma Q, et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol. 2004;15(12):3073–3082. Available from:https://www.ncbi.nlm.nih.gov/pubmed/15579510 doi:10.1097/01.ASN.0000145013.44578.45
9. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337–344. Available from:https://www.ncbi.nlm.nih.gov/pubmed/19176795 doi:10.2215/CJN.03530708
10. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365(9466):1231–1238. Available from:https://www.ncbi.nlm.nih.gov/pubmed/15811456 doi:10.1016/S0140-6736(05)74811-X
11. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22(12):2089–2095. Available from:https://www.ncbi.nlm.nih.gov/pubmed/17874137 doi:10.1007/s00467-007-0601-4
12. Wheeler DS, Devarajan P, Ma Q, et al. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a marker of acute kidney injury in critically ill children with septic shock. Crit Care Med. 2008;36(4):1297–1303. Available from:https://www.ncbi.nlm.nih.gov/pubmed/18379258 doi:10.1097/CCM.0b013e318169245a
13. Haase-Fielitz A, Bellomo R, Devarajan P, et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery--a prospective cohort study. Crit Care Med. 2009;37(2):553–560. Available from:https://www.ncbi.nlm.nih.gov/pubmed/19114878 doi:10.1097/CCM.0b013e318195846e
14. Smith ER, Lee D, Cai MM, et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant. 2013;28(6):1569–1579. Available from:https://www.ncbi.nlm.nih.gov/pubmed/23328709 doi:10.1093/ndt/gfs586
15. Kamijo-Ikemori A, Sugaya T, Kimura K., Urinary fatty acid binding protein in renal disease. Clin Chim Acta. 2006;374(1–2):1–7. Available from:https://www.ncbi.nlm.nih.gov/pubmed/16860300 doi:10.1016/j.cca.2006.05.038
16. McMahon BA, Murray PT., Urinary liver fatty acid-binding protein:another novel biomarker of acute kidney injury. Kidney Int. 2010;77(8):657–659. Available from:https://www.ncbi.nlm.nih.gov/pubmed/20354549 doi:10.1038/ki.2010.5
17. Yokoyama T, Kamijo-Ikemori A, Sugaya T, et al. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage. Am J Pathol. 2009;174(6):2096–2106. Available from:https://www.ncbi.nlm.nih.gov/pubmed/19435794 doi:10.2353/ajpath.2009.080780
18. Zimmermann MB, Hurrell RF., Nutritional iron deficiency. Lancet. 2007;370(9586):511–520. Available from:https://www.ncbi.nlm.nih.gov/pubmed/17693180 doi:10.1016/S0140-6736(07)61235-5
19. Schwartz GJ, Brion LP, Spitzer A., The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am. 1987;34(3):571–590. Available from:https://www.ncbi.nlm.nih.gov/pubmed/3588043 doi:10.1016/S0031-3955(16)36251-4
20. Subramaniam G, Girish M., Iron deficiency anemia in children. Indian J Pediatr. 2015;82(6):558–564. Available from:https://www.ncbi.nlm.nih.gov/pubmed/25636824 doi:10.1007/s12098-014-1643-9
21. Güneş A, Ece A, Aktar F, et al. Urinary kidney injury molecules in children with iron-deficiency anemia. Med Sci Monit. 2015;21:4023–4029. Available from:http://www.ncbi.nlm.nih.gov/pubmed/26697893 doi:10.12659/MSM.896794
22. Yazdani M, Merrikhi A, Beni ZN, et al. Association between neutrophil gelatinase-associated lipocalin and iron deficiency anemia in children on chronic dialysis. J Res Med Sci. 2014;19(7):624–628. Available from:https://www.ncbi.nlm.nih.gov/pubmed/25364361
23. El-Shimi MS, El-Farrash RA, Ismail EA, et al. Renal functional and structural integrity in infants with iron deficiency anemia:relation to oxidative stress and response to iron therapy. Pediatr Nephrol. 2015;30(10):1835–1842. Available from:http://www.ncbi.nlm.nih.gov/pubmed/25980471 doi:10.1007/s00467-015-3122-6
24. Sadeghi-Bojd S, Hashemi M, Salehi F., Renal tubular and glomerular function in children with iron deficiency anemia. Iran J Pediatr. 2009;19(3):231–236. Available from:http://ijp.tums.ac.ir/index.php/ijp/article/viewFile/855/854
25. Ozçay F, Derbent M, Aldemir D, et al. Effect of iron deficiency anemia on renal tubular function in childhood. Pediatr Nephrol. 2003;18(3):254–256. Available from:http://www.ncbi.nlm.nih.gov/pubmed/12644918
26. Altun D, Kurekci AE, Gursel O, et al. Malondialdehyde, antioxidant enzymes, and renal tubular functions in children with iron deficiency or iron-deficiency anemia. Biol Trace Elem Res. 2014;161(1):48–56. Available from:http://www.ncbi.nlm.nih.gov/pubmed/25099508 doi:10.1007/s12011-014-0084-7
27. Rao R, Georgieff MK., Iron in fetal and neonatal nutrition. Semin Fetal Neonatal Med. 2007;12(1):54–63. Available from:https://www.ncbi.nlm.nih.gov/pubmed/17157088 doi:10.1016/j.siny.2006.10.007
28. Koskenkorva-Frank TS, Weiss G, Koppenol WH, et al. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species:insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013;65:1174–1194. Available from:https://www.ncbi.nlm.nih.gov/pubmed/2403 doi:10.1016/j.freeradbiomed.2013.09.001